If you are a stakeholder from the undiagnosed diseases community-a genetic counselor, a patient or family, a clinical or research geneticist, a clinical lab technician, etc… -we are conducting a market research project at present and are very interested in your perspective. It’s a brief interview process-NOT a sales pitch-and you’d be helping us position our services in the best interest of patients and families looking for answers. If you are interested in participating in our research project or learning more about our approach to the discovery of genomic structural variations, please get in touch with us through the link provided below. We appreciate your consideration, please check back soon for more information! We offer dGH products and services for undiagnosed and genetic diseases screening. Through our work with the Undiagnosed Diseases Consortium and others within industry and academia, we have demonstrated the value of dGH as a discovery tool for screening genomes for structural variation. For UnDx, using De Novo dGH, we were able to discover a cryptic inversion- that was not detected by NGS -in an undiagnosed patient and a family member.